Approved Releases. If a Release requires consent pursuant to Section 10.1 or 10.2, once consent has been given both Parties may make subsequent public disclosure of the contents of such statement without the further approval of the Party whose consent was required; provided, such content is not presented with any new data or information or conclusions and/or in a form or manner that materially alters the subject matter therein.
Appears in 3 contracts
Samples: Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC), Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC), Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)
Approved Releases. If a Release requires consent pursuant to Section 10.1 Sections 10.3, 11.2 or 10.211.3, once consent has been given both Parties may make subsequent public disclosure of the contents of such statement without the further approval of the Party whose consent was required; provided, such content is not presented with any new data or information or conclusions and/or in a form or manner that materially alters the subject matter therein.
Appears in 2 contracts
Samples: License Agreement (Immunocore LTD), Collaboration Agreement (Immunocore LTD)
Approved Releases. If a Release requires consent pursuant to Section 10.1 10.2 or 10.2Section 10.3, once consent has been given both Parties may make subsequent public disclosure of the contents of such statement without the further approval of the Party whose consent was required; provided, such content is not presented with any new data or information or conclusions and/or in a form or manner that materially alters the subject matter therein.
Appears in 2 contracts
Samples: Exclusive Option and License Agreement (Yumanity Therapeutics, Inc.), Exclusive Option and License Agreement (Yumanity Therapeutics, Inc.)
Approved Releases. If a Release requires consent pursuant to Section 10.1 Sections 9.3 or 10.2, once consent has been given both Parties may make subsequent public disclosure of the contents of such statement without the further approval of the Party whose consent was required; provided, such content is not presented with any new data or information or conclusions and/or in a form or manner that materially alters the subject matter therein.
Appears in 2 contracts
Samples: License Agreement (Immunocore LTD), License Agreement (Immunocore LTD)
Approved Releases. If a Release requires consent pursuant to Section 10.1 Sections 16.3 or 10.217.2, once consent has been given both Parties may make subsequent public disclosure of the contents of such statement without the further approval of the Party whose consent was required; provided, such content is not presented with any new data or information or conclusions and/or in a form or manner that materially alters the subject matter therein.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Immunocore LTD), License and Collaboration Agreement (Immunocore LTD)
Approved Releases. If a Release requires consent pursuant to Section 10.1 or 10.2, this ARTICLE 12 once consent has been given both Parties may make subsequent public disclosure of the contents of such statement without the further approval of the Party whose consent was required; provided, such content is not presented with any new data or information or conclusions and/or in a form or manner that materially alters the subject matter therein.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Affimed N.V.)
Approved Releases. If a Release requires consent pursuant to Section 10.1 or 10.210.10, once consent has been given both Parties may make subsequent public disclosure of the contents of such statement Release (or the press release issued pursuant to Section 10.9) without the further approval of the Party whose consent was required; provided, provided that such content information remains accurate as of such time and is not presented with any new data or information or conclusions and/or or in a form or manner that materially alters the subject matter therein.
Appears in 1 contract
Samples: Collaboration and License Agreement (Recursion Pharmaceuticals, Inc.)
Approved Releases. If a Release requires consent pursuant to this Section 10.1 or 10.2β11.2, once consent has been given both Parties may make subsequent public disclosure of the contents of such statement without the further approval of the Party whose consent was required; provided, such content is not presented with any new data or information or conclusions and/or in a form or manner that materially alters the subject matter therein.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Affimed N.V.)